AI assistant
Pulmonx Corp — Director's Dealing 2025
Dec 11, 2025
34428_dirs_2025-12-10_b2c0b22c-8393-4e7f-81c6-c3dbf76844b2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2025-12-03
Reporting Person: Radhakrishnan Srikanth (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 181219 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $1.40 | 2030-06-24 | Common Stock (1383) | Direct | |
| Employee Stock Option (right to buy) | $2.20 | 2030-08-27 | Common Stock (20624) | Direct | |
| Employee Stock Option (right to buy) | $43.40 | 2031-05-31 | Common Stock (26600) | Direct | |
| Employee Stock Option (right to buy) | $26.56 | 2032-02-28 | Common Stock (43000) | Direct | |
| Employee Stock Option (right to buy) | $11.48 | 2033-02-28 | Common Stock (54000) | Direct | |
| Employee Stock Option (right to buy) | $9.30 | 2034-02-28 | Common Stock (31600) | Direct |
Footnotes
F1: Includes 149,227 shares of the Issuer's common stock underlying Restricted Stock Units payable solely in common stock of the Issuer.
F2: Fully vested.
F3: The number of shares reported reflects the shares remaining outstanding as of December 3, 2025 under this option grant.
F4: The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2022.
F5: The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2023.
F6: The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2024.